GNIPST Bulletin 47.2

17-07-2015

GGGNNNIIIPPPSSSTTT BBBUUULLLLLLEEETTTIIINNN 22200011155517th July, 2015 Volume No.: 47 Issue No.: 02

Vision

TO REACH THE PINNACLE OF GLORY AS A CENTRE OF EXCELLENCE IN THE FIELD OF PHARMACEUTICAL AND BIOLOGICAL SCIENCES BY KNOWLEDGE

BASED LEARNING AND PRACTICE

Contents Message from PRINCIPAL Editorial board Historical article News Update Knowledge based Article Disease Related Breaking

News Upcoming Events Drugs Update Campus News Students Section Editors Note Archive

GNIPST Photo Gallery For your comments/contribution OR For Back-Issues, mailto:[email protected]

GURU NANAK INSTITUTE OF PHARMACEUTICAL SCIENCE AND TECHNOLOGY

W e bs i t e : ht t p: / / gni ps t. a c. i n

17-07-2015

MESSAGE FROM PRINCIPAL

"It can happen. It does happen. But it can't happen if you quit." Lauren Dane.

We are what we repeatedly do. Excellence then is not an act, but a habit. Aristotle

It gives me immense pleasure to pen a few words for our e-bulletin. At the onset I would like to thank the last years editors and congratulate the newly selected editors for the current year.

Our first consideration is always in the best interest of the students. Our goal is to promote academic excellence and continuous improvement.

I believe that excellence in education is aided by creating a learning environment in which all learners are supported in maximizing their potential and talents. Education needs to focus on personalized learning and instruction, while promoting an education system that is impartial, universally accessible, and meeting the needs of all students.

It is of paramount importance that our learners have sufficient motivation and encouragement in order to achieve their aims. We are all very proud of you, our students, and your accomplishments and look forward to watching as you put your mark on the profession in the years ahead.

The call of the time is to progress, not merely to move ahead. Our progressive Management is looking forward and wants our Institute to flourish as a Post Graduate Institute of Excellence. Steps are taken in this direction and fruits of these efforts will be received by our students in the near future. Our Teachers are committed and dedicated for the development of the institution by imparting their knowledge and play the role of facilitator as well as role model to our students.

The Pharmacy profession is thriving with a multitude of possibilities, opportunities and positive challenges. At Guru Nanak Institute of Pharmaceutical Science and Technology, our focus is on holistic needs of our students.

I am confident that the students of GNIPST will recognize all the possibilities, take full advantage of the opportunities and meet the challenges with purpose and determination.

Excellence in Education is not a final destination, it is a continuous walk. I welcome you to join us on this path.

My best wishes to all.

Dr. A. Sengupta

Click here to go at the top

1

17-07-2015

EDITORIAL BOARD

CHIEF EDITOR DR. ABHIJIT SENGUPTA EDITOR MS. JEENATARA BEGUM ASSOCIATE EDITOR MR. DIPANJAN MANDAL

HISTORICAL ARTICLE J. Willard Gibbs (1839 1903) Willard Gibbs was a mathematical physicist who made enormous contributions to science: he founded modern statistical mechanics, he founded chemical thermodynamics, and he invented vector analysis. Early Life and Education Josiah Willard Gibbs was born on February 11, 1839 in New Haven, Connecticut, USA, the hometown of Yale University. Willard Gibbs family was prosperous and intellectual. His mothers name was Mary Anna Van Cleve. She came from an eminent family and was an amateur ornithologist. His fathers name was also Josiah Willard Gibbs. To avoid confusion, Gibbs Jr. was always known as Willard. His father, an expert on languages and linguistics, was a professor of sacred literature at Yale Universitys School of Divinity. Willard Gibbs was privately educated at Hopkins Grammar School until he enrolled at Yale University, aged just 15. He was awarded his degree four years later, in 1858, along with university prizes in mathematics and Latin. He immediately began working for an engineering Ph.D. at Yale, which he was awarded in 1863, at the age of 24. This was the first ever award of an engineering Ph.D. to any student at an American university. His highly mathematical thesis had the title: On the Forms of the Teeth of Wheels in Spur Gearing. Socially, Gibbs was quiet and bookish, a somewhat reserved student. Academically, he was brilliant.


2

17-07-2015

While Gibbs was a student, three significant events took place: In 1855, his mother died. In 1861, his father died, leaving Gibbs and his two sisters a

substantial inheritance, making them financially independent. From 186165 the American Civil War raged. Gibbs was not

conscripted: his health was fragile, and he suffered fromrespiratory problems. Also, his eyesight for reading was blurred,caused by astigmatism. He eventually had to grind lenses himselfto solve this problem.Gibbs Academic CareerTutoring at YaleYale University appointed Gibbs as a tutor in 1863. Tutors wereexpected to make themselves available to teach any of Yalescourses. Gibbs taught Latin for two years, followed by a yearteaching physics, while he continued privately to widen andsharpen his knowledge of engineering and the physical sciences.During this time he patented an improved railway car brake.Three Years in France and GermanyIn 1866 Gibbs and his sisters, Anna and Julia, set off on a three-yeartrip to Europe.Gibbs spent an academic year at each of the Sorbonne in Paris, andthe Universities of Berlin and Heidelberg in Germany. His single-minded purpose was to continue expanding and refining hisscientific knowledge.Like his father, he seems to have had a considerable gift forlanguages, so working in French and German caused him noproblems.France, Germany and the United Kingdom lay at the heart of thescientific world. Gibbs took a unique approach by spending threeyears studying in the non-English speaking countries, which gavehim a distinctive scientific viewpoint compared with otherAmerican scientists of the time.During the trip to Europe, Gibbs health was again a concern tuberculosis was suspected and he and his sisters moved to theFrench Riviera, hoping the warm, dry Mediterranean climate


3

17-07-2015

would help him. Thankfully, after a few months on the Riviera, he was pronounced free of tuberculosis. Professorship at Yale On his return to New Haven, Gibbs taught French for a time at Yale, and worked privately on some of his engineering ideas. In 1871 he was appointed Yales first professor of mathematical physics. The role was unpaid. Gibbs was happy with this situation he was a man of modest needs, and his inheritance provided himwith more than enough money. Furthermore, Gibbs was happy that the role required little teaching work, allowing him more thinking and research time. As his scientific reputation grew, other universities head-hunted him. Gibbs chose to stay at Yale, because he was happy in the familiar surroundings of his hometown and, also, Yales other scientists told him how much they valued his presence at the university. He stayed at Yale for the whole of his career and the University started paying him a salary to counterbalance offers he received from other institutions. Reshaping the Science of Thermodynamics In 1878 Gibbs published a third thermodynamics paper, the most revolutionary of them all. On the Equilibrium of Heterogeneous Substances Part II. In this paper Gibbs founded the science of chemical thermodynamics, entirely shaping our modern understanding of the field. This work lies at the heart of physical chemistry, telling us which chemical reactions are feasible. Unfortunately, Gibbs work was so highly mathematical that it took many years before its message was fully understood. If Gibbs had a fault, it was that he used mathematics to do nearly all of his talking for him. He felt little need to relate his mathematics and ideas to real-world examples and he was not concerned if people said his work was too hard to understand. Honors In 1880 Gibbs won the Rumford Prize of the American Academy of Arts and Sciences.


4

17-07-2015

In 1901 he was awarded the British Royal Societys Copely Medal, which was then the greatest prize in science, equal to a Nobel Prize today; and a rarer award, since only one Copely Medal was awarded each year. The award citation stated that Gibbs was: the first to apply the second law of thermodynamics to the exhaustive discussion of the relation between chemical, electrical, and thermal energy and capacity for external work. Some Personal Details and the End Except for three years in Europe, Gibbs lived all his life in the large family home his father built in New Haven, Connecticut. This steady life suited him, because he was a man who enjoyed regularity and order. There is an irony in this, given that Gibbs significantly advanced our understanding of entropy which is often characterized as disorder. He attended church regularly and left New Haven only during his summer vacations, which he liked to spend in the mountains. Gibbs was perceived by people who knew him as kind, sympathetic and happy. He never married. He shared the family home with his sisters: Anna, who remained unmarried; and Julia, her husband and children. Josiah Willard Gibbs died at the age of 64 on April 28, 1903, just a year after he published his seminal work on statistical thermodynamics. His death was caused by an intestinal obstruction. He was buried in the Grove Street Cemetery, New Haven.

NEWS UPDATE New limb-lengthening technique is less

cumbersome for patients: 17th July, 2015 A highly specialized procedure that lengthens bones can prevent the need for amputations in selected patients who have suffered severe fractures. And now a new study has found that an alternative limb-lengthening technique makes the long recovery


5

17-07-2015

process less cumbersome -- while still providing good-to-excellent outcomes.

Can cholesterol-lowering drugs help treat acute Ebola cases? : 17th July, 2015 In the course of basic research in membrane biochemistry scientists have gained new insight into the cytotoxic effect of the Ebola virus. Employing biochemical and cell biological methods they have shed light on the molecular relationships between the Ebola glycoprotein and its role in mediating cytotoxicity. Researchers discovered that the virus glycoprotein interacts with cellular cholesterol, thus prompting the use of certain cholesterol-lowering agents in their investigations. The researchers report they succeeded in suppressing cellular damage in cell cultures.

Researchers test bioartificial liver device to treat acute liver failure: 17th July, 2015 Researchers have developed and are testing an alternative to liver transplantation called the Spheroid Reservoir Bioartificial Liver that can support healing and regeneration of the injured liver, and improve outcomes and reduce mortality rates for patients with acute liver failure.

Dairy products boost effectiveness of probiotics: 17th July, 2015 The success of probiotics for boosting human health may depend partly upon the food, beverage, or other material carrying the probiotics, according to research.

Cholesterol metabolism in immune cells linked to HIV progression: 17th July, 2015 Lower levels of cholesterol in certain immune cells -- a result of enhanced cholesterol metabolism within those cells -- may help explain why some HIV-infected people are able to naturally control disease progression, according to research. The findings provide a basis for potential development of new approaches to


6

17-07-2015

control HIV infection by regulating cellular cholesterol metabolism.

Lymphomas tied to metabolic disruption: 17th July, 2015 Direct links between disrupted metabolism and an often fatal type of lymphoma have been uncovered by researchers.

Study in mice may identify new ways to treat immune thrombocytopenia: 17th July, 2015 A study in mice may identify new ways to treat immune thrombocytopenia. Immune thrombocytopenia, or ITP, is an autoimmune disease whereby the immune system sends antibodies to attack and destroy the body's platelets--blood cells responsible for controlling bleeding.

Moderate hormone suppression may be enough in thyroid cancer, 30-year study shows: 17th July, 2015 Moderate suppression of thyroid-stimulating hormone, which drives thyroid cancer, may be as beneficial as more extreme hormone suppression, a study of long-term thyroid cancer outcomes shows. Extreme TSH suppression is associated with increased side effects including osteoporosis and heart rhythm irregularities.

Personalized care for aortic aneurysms, based on gene testing, has arrived: 16th July, 2015 Researchers have tested the genomes of more than 100 patients with thoracic aortic aneurysms, a potentially lethal condition, and provided genetically personalized care. Their work will also lead to the development of a 'dictionary' of genes specific to the disease, according to researchers.


7

17-07-2015

Emissions have declined, but sulfur dioxide air pollutant still a concern for asthmatics: 16th July, 2015 Emissions of the air pollutant sulfur dioxide have been dramatically decreased during the past 30 years but for some people even a little inhaled sulfur dioxide may still be too much. For detail mail to editor

KNOWLEDGE BASED ARTICLE Miniature brains made from patient skin cells

reveal insights into autism Understanding diseases like autism and schizophrenia that affect development of the brain has been challenging due to both the complexity of the diseases and the difficulty of studying developmental processes in human tissues. In a study published July 16 in Cell, researchers have made steps toward overcoming these challenges by converting skin cells from autism patients into stem cells and growing them into tiny brains in a dish, revealing unexpected mechanisms of the disease. Most autism research has taken the approach of combing through patient genomes for mutations that may underlie the disorder and then using animal or cell-based models to study the genes and their possible roles in brain development. Although this has yielded a handful of rare disease genes, the limitations of these models and the complexity of the disorder have frustrated researchers and left over 80% of autism cases with no clear genetic cause. The new study now turns the traditional approach on its head. "Instead of starting from genetics, we've started with the biology of the disorder itself to try to get a window into the genome," says senior author Flora Vaccarino the Harris Professor of Child Psychiatry and Professor or Neurobiology at the Yale School of Medicine.


8

17-07-2015

The clinical characteristics of autism are complex and wide-ranging, making the prospect of finding common underlying factors slim. To stack the deck in their favor, the researchers focused on the approximately one-fifth of autism patients that share a distinctive feature correlated with disease severity--an enlarged brain. After isolating skin cells from these individuals, as well as their unaffected fathers to provide a point of comparison, the researchers converted the cells into induced pluripotent stem cells that were then grown into miniature brains. These so-called "brain organoids" are just a few millimeters in diameter but mimic the basics of early human brain development, roughly corresponding to the first few months of gestation. When the researchers analyzed the patient organoids, they uncovered altered expression networks for genes controlling neuronal development. Patient organoids showed an unexpected overproduction of inhibitory neurons that quiet down neural activity, while those that excite the partners they're wired to were unaffected, leading to an imbalance in neuron type. Remarkably, by suppressing the expression of a single gene whose expression was abnormally increased in patient organoids, the authors were able to correct this bias, suggesting that it may be possible to intervene clinically to restore neuronal balance. With current technology, human brain organoids only recapitulate early stages of development; however, efforts to extend their growth to later stages are under way by a number of groups and will allow even further insights into disease mechanisms. The authors are now using their data to home in on the difficult-to-find mutations or epigenetic changes responsible for the gene expression alterations and neuronal imbalance observed in the study. According to Vaccarino: "This study speaks to the importance of using human cells and using them in an assay that could bring a better understanding of the pathophysiology of autism and with that, possibly better treatments." The success of the approach also suggests that similar methods might be used to gain important


9

17-07-2015

insights into other human developmental diseases that have until now been difficult to crack open. This work was primarily supported by the National Institutes of Health, the Harris Professorship fund, The National Institute of Mental Health, the State of Connecticut, and the Foster-Davis Foundation Inc. through the Brain and Behavior Research Foundation.

Jeenatara Begum Assistant Professor

GNIPST

DISEASE RELATED BREAKING NEWS Middle East respiratory syndrome coronavirus

(MERS-CoV) Republic of Korea : 17th July, 2015 Situation in the Republic of Korea Between 15 and 17 July 2015, the National IHR Focal Point of the Republic of Korea notified WHO of no additional cases of infection and no new deaths related to Middle East Respiratory Syndrome Coronavirus (MERS-CoV). Read more

UPCOMING EVENTS 61st IPSF World Congress sponsored by Indian Pharmaceutical

Association (IPA) at Marriott Hotel, Hyderabad, India is going to on 30th July to 9th August, 2015.

For further details please visit www.ipsf2015.org


10

17-07-2015

DRUGS UPDATES Ipsen Announces FDA Approval of Dysport

(abobotulinumtoxinA) for Upper Limb Spasticity: 16th July, 2015 Ipsen (Euronext: IPN; ADR: IPSEY) announced that the U.S. Food and Drug Administration (FDA) has approved its supplemental Biologics License Application (sBLA) for Dysport (abobotulinumtoxinA) for the treatment of upper limb spasticity in adult patients after the submission of the dossier in September 2014. Dysport is now approved for the treatment of upper limb spasticity in adult patients, to decrease the severity of increased muscle tone in elbow flexors, wrist flexors and finger flexors. Clinical improvement may be expected one week after administration of Dysport. A majority of patients in clinical studies were retreated between 12 and 16 weeks; some patients had a duration of response as long as 20 weeks. In Europe, regulatory procedures are in progress for strengthening the existing upper limb spasticity label indication of Dysport to include key medical data such as muscle dose recommendations, treatment intervals, efficacy data and safety updates. Read more

CAMPUS NEWSFAREWELL PROGRAMME:

On 15th May 2015 GNIPST clebrated the farewell programme Sesh Chithi for the final year students of M.Pharm, M.Sc, B.Pharm, B.Sc and BHM.

JIS SAMMAN 2015 On 11th May, 2015 GNIPST attended the JIS SAMMAN 2015.

JIS SAMMAN Awards: Best College (Non Engineering):

GNIPST Best Principal:


11

17-07-2015

Dr (Prof.) Avijit Sengupta Best HOD:

Mr. Jaydip Ray Best Faculty:

Mr. Debabrata Ghoshdastidar (Pharmacy)Dr. Swati Chakraborty (Life Sciences)

Best faculty since inception:Mr. Jaydip Ray

Best Office Staff:Ms. Jaya Banerjee

Best technical Assistant:Mr. Somnath Majhi

College Blue:Avik Paul

Highest DGPA of 2014:B.Pharm:

Purbali Chakraborty (4th year) Diksha Kumari (3rd year) Aishika Dutta (2nd year) Sampita Paul (1st year) M.Pharm: Aritra Mukherjee (Pharmaceutical Chemistry) Mounomukhar Bhattacharya (Pharmacology) B.Sc (Biotechnology): Papiya Saha (3rd year) Shomasree Das (2nd year) Ayanita Basak (1st year) B.Sc (Microbiology): Bonhisikha Chatterjee (3rd year) Riaz Hossain (2nd year) Soumi Chowdhury (1st year) BHM: Bishal Roy (3rd year) Shreyabhanja Chowdhury (2nd year)


12

17-07-2015

Recitation: Udita Majumder Debate:

Srijita Roy Poushali Ganguly Quiz:

Arani Ray Dipayan Nath Band:

Syantan Ghoswami Anurag Ghosh Atanu Mondal Arka Khamaru Ritobroto Paul Abhirup Dasgupta

Fashion: Md. Nadeem Shah Koustav Sarkar Shaksar Saha Avirup Dasgupta Ranit Kundu Namrata Ganguly Shreyasee Mitra Chandrika Saha Debopriya Chatterjee Riya Taran

Innovative Modeling: Ankit Chowdhury Kartik Koley Mudasar Manna Dipan Chaterjee Abhishek Singh Kaustav Pal Manojit Dutta


13

17-07-2015

SPIRIT JIS 2015 On 03th to 05th April, 2015 JIS organised SPIRIT JIS 2015. GPAT 2015 Result:

The following B.Pharm. final year students have qualified, GPAT-2015. We congratulate them all. Diksha Kumari Rupanjay Bhattacharya Avik Paul Xtasy 2015: GNIPST is going to organize the Tech Fest Xtasy 2015 from 30th March, 2015 to 1st April, 2015.

FINISHING SCHOOL TRAINING PROGRAMME: The FINISHING SCHOOL TRAINING PROGRAMME is going to organize by the Entrepreneurship Development Cell and Training & Placement Cell, GNIPST in collaboration with Indian Pharmacy Graduates Association (IPGA), Bengal Branch from 21st February to 11th April, 2015 at GNIPST Auditorium. On 21

st February, 2015 the Finishing School Training Programme of

GNIPST was inaugurated by Sri Soumen Mukhopadhyay, Deputy Director, Drug Control Office, Goutam Kr. Sen, President, IPGA, Mr. Subroto Saha, Asst. Directorate, Drug Control Office, Mr. Ranendra Chakraborty, Sales Manager and Associate Director Dr. Reddys Laboratory. On 28th February, 2015 Dr. D. Roy, Former Deputy Drug Controller, Mr. Sujoy Chakraborty, divisional Therapy Manager, Cipla and Mr. Vikranjit Biswas, Senior Manager, Learning & Development, Cipla delivered their valuable lectures in the 2nd day FINISHING SCHOOL TRAINING PROGRAMME of GNIPST. On 14th March, 2015 Mr. Milindra Bhattacharya, Senior Manager, QA & QC, Emami Ltd. and Mr. Joydev Bhoumik, Manager, Operation, Ranbaxy Laboratory Limited delivered their valuable lectures in the 3rd day FINISHING SCHOOL TRAINING PROGRAMME of GNIPST.


14

17-07-2015

On 21st March, 2015 Mr. Tridib Neogi, Associate Vice-President (Quality Assurance), Albert David Ltd. delivered his valuable lectures in the 4th FINISHING SCHOOL TRAINING PROGRAMME of GNIPST. On 28th March, 2015 Dr. Gautam Chaterjee, an Alumni of Jadavpur University and presently associated with NIPER delivered his valuable lectures in the 5th FINISHING SCHOOL TRAINING PROGRAMME of GNIPST. On 11th April, 2015 the closing ceremony of the FINISHING SCHOOL TRAINING PROGRAMME was held in GNIPST Auditorium.

JOBS: All the students of Final Year B. Pharm and M. Pharm are hereby informed that an interview will be conducted on 23rd May, 2015 by Standard Pharmaceuticals Ltd. GSK for post: Production, QA, QC. All the students of Final Year B. Pharm and M. Pharm are hereby informed that an interview will be conducted by GSK for sales and marketing job. Details given below:

Date: 27.03.2015Time: 09:45 amVenue : GSK Consumer Healthcare Limited, Unit No. 208,

2nd Floor, Ecospace Campus B (3 B), New Town, Rajarhat, 24 Pgs (N). Kolkata-700156.

THYROCARE provisionally selected 15 students from JIS Group. Amongst these, 3 students of B. Sc (H) Biotechnology and M. Sc Biotechnology have been selected. Ipsita Mondal (M. Sc Biotechnology)Debriti Paul (M. Sc Biotechnology)Debopriya Chatterjee {B. Sc (H) Biotechnology}

The final year students of B.Pharm (31 students) and B.Sc (11 students) attended the pooled campus drive of Abbott India Ltd. on 10th March, 2015 at Jadavpur University. Among them 17 students have gone through to the final round of this pooled campus drive and short listed for final selection.


15

17-07-2015

ACHIEVEMENT: Congratulations to Anurag Chanda, student of B.Pharm final year

who have got the 1st prize in poster presentation event in Prakriti 2015 at Department of Agricultural and Food engineering, IIT, Kharagpur.

OTHERS: On 24th and 25th February, 2015 Swamiji of Gourio Mathwasdelivered some motivational lectuers in GNIPST.

The students of GNIPST participated in the 4th Sardar JodhSinghTrophy organised by NIT on 20th February, 2015. On 8th February, 2015 Gnipst celebrated the ReunionprogrammeReminiscence Reloaded 2015.

STUDENTS SECTION WHO CAN ANSWER FIRST????

Peru,oya and Kuroshio are types ofwhich geographical phenomenon?

Answer of Previous Issues Questions: Dopamin

Identify the person

Answer of Previous Issues Image: Lewis Carroll


16

17-07-2015

Send your thoughts/Quiz/Puzzles/games/write-ups or any other contributions for Students Section& answers of this Section at [email protected] NOTE

It is a great pleasure for me to publish the 2nd issue of 47th Volume of GNIPST BULLETIN. All the followers of GNIPST BULLETIN are able to avail the bulletin through facebook account GNIPST bulletin I am very much thankful to all the GNIPST members and readers who are giving their valuable comments, encouragements and supports. I am also thankful to Dr. Abhijit Sengupta, Director of GNIPST for his valuable advice and encouragement. Special thanks to Dr. Prerona Saha, Mr. Debabrata Ghosh Dastidar and Mr. Soumya Bhattacharya for their kind co-operation and technical supports. Thank you Mr. Soumya Bhattacharya for the questionnaires of the student section. An important part of the improvement of the bulletin is the contribution of the readers. You are invited to send in your write ups, notes, critiques or any kind of contribution for the forthcoming special and regular issue.

ARCHIVE The general body meeting of APTI, Bengal Branch has been

conducted at GNIPST on 15th June, 2012. The program started witha nice presentation by Dr. Pulok Kr. Mukherjee, School of NaturalProducts, JU on the skill to write a good manuscript forpublication in impact journals. It was followed by nearly two hourlong discussion among more than thirty participants on differentaspects of pharmacy education. Five nonmember participantsapplied for membership on that very day.


17

17-07-2015

GNIPST is now approved by AICTE and affiliated to WBUT forconducting the two years post graduate course (M.Pharm)in PHARMACOLOGY. The approved number of seat is 18.

The number of seats in B.Pharm. has been increased from 60 to120.

AICTE has sanctioned a release of grant under ResearchPromotion Scheme (RPS) during the financial year 2012-13toGNIPST as per the details below:a. Beneficiary Institution: Guru Nanak Institution of PharmaceuticalScience & Technology.

b. Principal Investigator: Dr. LopamudraDutta.c. Grant-in-aid sanctioned:Rs. 16,25000/- only

d. Approved duration: 3 yearse. Title of the project: Screening and identification of potential

medicinal plant of Purulia & Bankura districts of West Bengal with respect to diseases such as diabetes, rheumatism, Jaundice, hypertension and developing biotechnological tools for enhancing bioactive molecules in these plants.

Activity Clubs of GNIPST: Name of Club Member Faculty SPORTS Mr. Debabrata GhoshDastidar LITERARY AND PAINTING Ms. Jeenatara Begum SCIENCE AND INNOVATIVE MODELLING

Mr. Samrat Bose

ECO Ms. Sumana Roy SOCIAL SERVICES Dr. Asis Bala PHOTOGRAPHY Ms. Sanchari Bhattacharya CULTURAL Ms. Priyanka Ray DEBATE AND EXTEMPORE Mr. Soumya Bhattacharya


18

J. Willard Gibbs (1839 1903)Willard Gibbs was a mathematical physicist who made enormous contributions to science: he founded modern statistical mechanics, he founded chemical thermodynamics, and he invented vector analysis.Early Life and EducationGibbs Academic Career

Gibbs spent an academic year at each of the Sorbonne in Paris, and the Universities of Berlin and Heidelberg in Germany. His single-minded purpose was to continue expanding and refining his scientific knowledge.Reshaping the Science of ThermodynamicsHonorsSome Personal Details and the End

New limb-lengthening technique is less cumbersome for patients: 17th July, 2015A highly specialized procedure that lengthens bones can prevent the need for amputations in selected patients who have suffered severe fractures. And now a new study has found that an alternative limb-lengthening technique makes the long recovery proc... Can cholesterol-lowering drugs help treat acute Ebola cases? : 17th July, 2015In the course of basic research in membrane biochemistry scientists have gained new insight into the cytotoxic effect of the Ebola virus. Employing biochemical and cell biological methods they have shed light on the molecular relationships between the... Researchers test bioartificial liver device to treat acute liver failure: 17th July, 2015Researchers have developed and are testing an alternative to liver transplantation called the Spheroid Reservoir Bioartificial Liver that can support healing and regeneration of the injured liver, and improve outcomes and reduce mortality rates for pa... Dairy products boost effectiveness of probiotics: 17th July, 2015The success of probiotics for boosting human health may depend partly upon the food, beverage, or other material carrying the probiotics, according to research. Cholesterol metabolism in immune cells linked to HIV progression: 17th July, 2015Lower levels of cholesterol in certain immune cells -- a result of enhanced cholesterol metabolism within those cells -- may help explain why some HIV-infected people are able to naturally control disease progression, according to research. The findin... Lymphomas tied to metabolic disruption: 17th July, 2015Direct links between disrupted metabolism and an often fatal type of lymphoma have been uncovered by researchers. Study in mice may identify new ways to treat immune thrombocytopenia: 17th July, 2015A study in mice may identify new ways to treat immune thrombocytopenia. Immune thrombocytopenia, or ITP, is an autoimmune disease whereby the immune system sends antibodies to attack and destroy the body's platelets--blood cells responsible for contro... Moderate hormone suppression may be enough in thyroid cancer, 30-year study shows: 17th July, 2015Moderate suppression of thyroid-stimulating hormone, which drives thyroid cancer, may be as beneficial as more extreme hormone suppression, a study of long-term thyroid cancer outcomes shows. Extreme TSH suppression is associated with increased side e... Personalized care for aortic aneurysms, based on gene testing, has arrived: 16th July, 2015Researchers have tested the genomes of more than 100 patients with thoracic aortic aneurysms, a potentially lethal condition, and provided genetically personalized care. Their work will also lead to the development of a 'dictionary' of genes specific ... Emissions have declined, but sulfur dioxide air pollutant still a concern for asthmatics: 16th July, 2015Emissions of the air pollutant sulfur dioxide have been dramatically decreased during the past 30 years but for some people even a little inhaled sulfur dioxide may still be too much.For detail mail to editor

KNOWLEDGE BASED ARTICLEMiniature brains made from patient skin cells reveal insights into autism Middle East respiratory syndrome coronavirus (MERS-CoV) Republic of Korea : 17th July, 2015Situation in the Republic of Korea

Read more Ipsen Announces FDA Approval of Dysport (abobotulinumtoxinA) for Upper Limb Spasticity: 16th July, 2015Ipsen (Euronext: IPN; ADR: IPSEY) announced that the U.S. Food and Drug Administration (FDA) has approved its supplemental Biologics License Application (sBLA) for Dysport (abobotulinumtoxinA) for the treatment of upper limb spasticity in adult patien... CAMPUS NEWS STUDENTS SECTION

Documents

GNIPST Bulletin 47.2